Francisco Antonio N.
- Country
- Spain
- Department
- Pediatrics
Research Overview
- Evaluation of Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Pediatric Patients with Complicated Urinary Tract Infections
- Evaluation of Pharmacokinetics, Safety, and Efficacy of Empagliflozin in Pediatric Patients with Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 3 of 57 partner sites.
Specializations
Pediatric Infectious Diseases
This investigator specializes in treating complicated urinary tract infections and acute pyelonephritis in pediatric populations, focusing on children from early infancy through adolescence.
- Pediatric Urology
- Antimicrobial Therapy
- Urinary Tract Infections
Particular emphasis is placed on addressing complex infections in the pediatric urinary system, requiring specialized therapeutic approaches.
Clinical Pharmacology
The investigator focuses on understanding pharmacokinetics in pediatric patients, specifically studying how medications are processed in young bodies across different age groups.
- Drug Absorption Studies
- Pediatric Drug Tolerance
- Age-Specific Therapeutic Responses
Their work encompasses the evaluation of medication safety and efficacy in children from 3 months to 18 years of age.
Pediatric Therapeutics
Expertise in developing therapeutic strategies for complex pediatric infections, with a focus on age-appropriate treatment protocols.
- Intravenous Therapy
- Infection Management
- Pediatric Drug Safety
The investigator specializes in evaluating treatment responses in different pediatric age groups requiring intensive antibiotic therapy.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.